Benzinga | Oct 27, 2021 07:00AM EDT

Bristol-Myers Squibb Q3 Adj. EPS $2.00 Beats $1.92 Estimate, Sales $11.62B Beat $11.58B Estimate; Raises Low End Of FY21 Adj. EPS Guidance

Bristol-Myers Squibb (NYSE:BMY) reported quarterly earnings of $2.00 per share which beat the analyst consensus estimate of $1.92 by 4.17 percent. This is a 22.7 percent increase over earnings of $1.63 per share from the same period last year. The company reported quarterly sales of $11.62 billion which beat the analyst consensus estimate of $11.58 billion by 0.38 percent. This is a 10.28 percent increase over sales of $10.54 billion the same period last year.